Literature DB >> 22790552

Gynecomastia: physiopathology, evaluation and treatment.

Alfredo Carlos Simões Dornellas de Barros1, Marcelo de Castro Moura Sampaio.   

Abstract

Gynecomastia (GM) is characterized by enlargement of the male breast, caused by glandular proliferation and fat deposition. GM is common and occurs in adolescents, adults and in old age. The aim of this review is to discuss the pathophysiology, etiology, evaluation and therapy of GM. A hormonal imbalance between estrogens and androgens is the key hallmark of GM generation. The etiology of GM is attributable to physiological factors, endocrine tumors or dysfunctions, non-endocrine diseases, drug use or idiopathic causes. Clinical evaluation must address diagnostic confirmation, search for an etiological factor and classify GM into severity grades to guide the treatment. A proposal for tailored therapy is presented. Weight loss, reassurance, pharmacotherapy with tamoxifen and surgical correction are the therapeutic options. For long-standing GM, the best results are generally achieved through surgery, combining liposuction and mammary adenectomy.

Entities:  

Mesh:

Year:  2012        PMID: 22790552     DOI: 10.1590/s1516-31802012000300009

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  18 in total

1.  Breast US as primary imaging modality for diagnosing gynecomastia.

Authors:  M Telegrafo; T Introna; L Coi; I Cornacchia; L Rella; A A Stabile Ianora; G Angelelli; M Moschetta
Journal:  G Chir       Date:  2016 May-Jun

2.  Fluoxymesterone-induced gynaecomastia in a patient with childhood aplastic anaemia.

Authors:  Tom Edward Ngo Lo; Zillien C Andal; Frances Lina Lantion-Ang
Journal:  BMJ Case Rep       Date:  2015-05-06

3.  A Clinical, Etiological, and Therapeutic Profile of Gynecomastia.

Authors:  Lamiaa Elazizi; Mohammed Amine Essafi; Aabi Hanane; Hayat Aynaou; Houda Salhi; Hanan El Ouahabi
Journal:  Cureus       Date:  2022-08-04

4.  Gynecomastia in subjects with sexual dysfunction.

Authors:  E Maseroli; G Rastrelli; G Corona; V Boddi; A M L Amato; E Mannucci; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2014-02-11       Impact factor: 4.256

5.  α1-Adrenergic receptor antagonists and gynecomastia. A case series from the Italian spontaneous reporting system and VigiBase(™).

Authors:  Ermelinda Viola; Sibilla Opri; Ugo Moretti; Roberto Leone; Maria Luisa Casini; Sara Ruggieri; Claudia Minore; Anita Conforti
Journal:  Eur J Clin Pharmacol       Date:  2014-06-03       Impact factor: 2.953

6.  Gynaecomastia in the Durban Breast Unit: A Comparison of HIV- and Non-HIV-Infected Individuals.

Authors:  Safeeya Osman; E Mansoor; I Buccimazza
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

7.  Prevalence of Incidental Gynecomastia by Chest Computed Tomography in Patients with a Prediagnosis of COVID-19 Pneumonia.

Authors:  Özge Aslan; Selen Bayraktaroğlu; Akın Çinkooğlu; Naim Ceylan; Recep Savaş; Ayşenur Oktay
Journal:  Eur J Breast Health       Date:  2021-03-31

8.  Cases of antiretroviral-associated gynaecomastia reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa.

Authors:  Christine Njuguna; Annoesjka Swart; Marc Blockman; Gary Maartens; Briony Chisholm; Annemie Stewart; Anri Uys; Karen Cohen
Journal:  AIDS Res Ther       Date:  2016-11-16       Impact factor: 2.250

Review 9.  Gynecomastia in Patients with Prostate Cancer: A Systematic Review.

Authors:  Anders Fagerlund; Luigi Cormio; Lina Palangi; Richard Lewin; Fabio Santanelli di Pompeo; Anna Elander; Gennaro Selvaggi
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

Review 10.  Gynecomastia: Clinical evaluation and management.

Authors:  Neslihan Cuhaci; Sefika Burcak Polat; Berna Evranos; Reyhan Ersoy; Bekir Cakir
Journal:  Indian J Endocrinol Metab       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.